Inventor · disambiguated record
Nahoko Baileykobayashi
Also filed as: BAILEYKOBAYASHI Nahoko
30 granted patents·10 pending applications·15 citations·filing 2014–2024
92Inventor score
Files withTOAGOSEI CO LTD40
Top patents by PatentIndex Score
40 records- 0194US11313862B2Method for diagnosing amyotrophic lateral sclerosis using signal peptide as indicatorTOAGOSEI CO LTD·Filed 2017·Granted Apr 26, 2022·8 cites·12 claims
- 0291US11927589B2Carrier peptide fragment for nucleolar localization and use thereofTOAGOSEI CO LTD·Filed 2022·Granted Mar 12, 2024·1 cites·8 claims
- 0378US11230586B2Exosome production methodTOAGOSEI CO LTD·Filed 2020·Granted Jan 25, 2022·1 cites·7 claims
- 0478US10100284B2Method for inducing differentiation of pluripotent stem cells into endodermal cellsTOAGOSEI CO LTD·Filed 2014·Granted Oct 16, 2018·2 cites·8 claims
- 0577US2025129368A1siRNA based on RNA sequence of SARS-CoV-2 and use thereofTOAGOSEI CO LTD·Filed 2024·Application pending·0 cites
- 0676US11965011B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2022·Granted Apr 23, 2024·0 cites·8 claims
- 0774US11299555B2Method for diagnosing alzheimer's disease using signal peptide as indicatorTOAGOSEI CO LTD·Filed 2017·Granted Apr 12, 2022·1 cites·3 claims
- 0871US10046022B2Synthetic peptide that increases radiosensitivity of tumor cells and use of sameTOAGOSEI CO LTD·Filed 2016·Granted Aug 14, 2018·1 cites·12 claims
- 0970US12209242B2siRNA based on RNA sequence of SARS-CoV-2 and use thereofTOAGOSEI CO LTD·Filed 2022·Granted Jan 28, 2025·0 cites·3 claims
- 1070US11505589B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2019·Granted Nov 22, 2022·0 cites·2 claims
- 1169US10112977B2Peptide for inducing multinucleation in cells, and use thereforTOAGOSEI CO LTD·Filed 2015·Granted Oct 30, 2018·1 cites·9 claims
- 1268US2024182577A1Anti-pd-1 signal peptide antibody and use thereofTOAGOSEI CO LTD·Filed 2024·Application pending·0 cites
- 1367US12285476B2Amino acid sequence derived from S protein of SARS-CoV2 for generating an anti-SARS-CoV-2 antibodyTOAGOSEI CO LTD·Filed 2022·Granted Apr 29, 2025·0 cites·6 claims
- 1466US11814448B2Carrier peptide fragment and use thereofTOAGOSEI CO LTD·Filed 2021·Granted Nov 14, 2023·0 cites·6 claims
- 1565US12392770B2Foreign substance introduction construct and use thereofTOAGOSEI CO LTD·Filed 2023·Granted Aug 19, 2025·0 cites·9 claims
- 1665US2025262333A1Construct for Transferring Foreign Substance, and Use ThereofTOAGOSEI CO LTD·Filed 2023·Application pending·0 cites
- 1765US2025382331A1Carrier Peptide Fragment and Use ThereofTOAGOSEI CO LTD·Filed 2023·Application pending·0 cites
- 1863US11767345B2Antiviral peptide and use thereofTOAGOSEI CO LTD·Filed 2021·Granted Sep 26, 2023·0 cites·2 claims
- 1962US11780903B2Peptide suppressing binding of CTLA4 to B7 proteins, and use thereofTOAGOSEI CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·3 claims
- 2060US2024262863A1Peptide fragment and use thereofTOAGOSEI CO LTD·Filed 2022·Application pending·0 cites
- 2160US2022089641A1Carrier Peptide Fragment and Use ThereofTOAGOSEI CO LTD·Filed 2021·Application pending·0 cites
- 2258US11603395B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2020·Granted Mar 14, 2023·0 cites·8 claims
- 2358US2022008547A1Carrier Peptide Fragment and use ThereofTOAGOSEI CO LTD·Filed 2021·Application pending·0 cites
- 2457US2023399368A1Carrier peptide fragment and use thereofTOAGOSEI CO LTD·Filed 2021·Application pending·0 cites
- 2557US2023272005A1Amino Acid Sequence Derived from Sars-Cov-2 and Use ThereofTOAGOSEI CO LTD·Filed 2021·Application pending·0 cites
- 2656US11352408B2Antitumor peptide having PD-1 signal sequence and utilization thereofTOAGOSEI CO LTD·Filed 2018·Granted Jun 7, 2022·0 cites·3 claims
- 2756US11155582B2Antiviral peptide and use thereofTOAGOSEI CO LTD·Filed 2019·Granted Oct 26, 2021·0 cites·13 claims
- 2855US10981953B2Method for promoting expression of calreticulin, and synthetic peptide for use in method for promoting expression of calreticulinTOAGOSEI CO LTD·Filed 2014·Granted Apr 20, 2021·0 cites·11 claims
- 2953US11285195B2Pharmaceutical composition for inhibiting expression of CD47 in tumor cells and use of sameTOAGOSEI CO LTD·Filed 2018·Granted Mar 29, 2022·0 cites·6 claims
- 3051US11472845B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2020·Granted Oct 18, 2022·0 cites·8 claims
- 3151US10745448B2Antiviral peptide and use thereforTOAGOSEI CO LTD·Filed 2018·Granted Aug 18, 2020·0 cites·5 claims
- 3250US2020005905A1Method for assisting in diagnosis of three major neurodegenerative diseasesTOAGOSEI CO LTD·Filed 2019·Application pending·0 cites
- 3348US11339203B2Antitumor peptide and use thereofTOAGOSEI CO LTD·Filed 2019·Granted May 24, 2022·0 cites·4 claims
- 3448US9856293B2Methods for inducing nestin expression of astrocytes by nestin-inducing synthetic peptides derived from the BC-box of the SOCS6 proteinTOAGOSEI CO LTD·Filed 2014·Granted Jan 2, 2018·0 cites·7 claims
- 3547US10421944B2Method for producing neural stem cells using synthetic peptideTOAGOSEI CO LTD·Filed 2016·Granted Sep 24, 2019·0 cites·6 claims
- 3645US10829523B2Anti-tumor peptides and use thereofTOAGOSEI CO LTD·Filed 2017·Granted Nov 10, 2020·0 cites·4 claims
- 3744US11324831B2Method for introducing exogenous substance into cell, and material used in said methodTOAGOSEI CO LTD·Filed 2017·Granted May 10, 2022·0 cites·7 claims
- 3843US10067145B2Method for removing genomically unstable IPS cells and synthetic peptide used thereforTOAGOSEI CO LTD·Filed 2014·Granted Sep 4, 2018·0 cites·17 claims
- 3941US11359180B2Method for producing myocardial cells using synthetic peptideTOAGOSEI CO LTD·Filed 2016·Granted Jun 14, 2022·0 cites·14 claims
- 4038US10138469B2Synthetic peptide and use thereofTOAGOSEI CO LTD·Filed 2015·Granted Nov 27, 2018·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Nahoko Baileykobayashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →